Researchers find new mechanism to turn on cancer-killing T cells

A new mechanism involved in the anti-cancer immune response has been identified and may have implications for targeting antigens.

CAR T-cell therapy recipient surpasses 5-year cancer-free mark
Diffuse large B-cell lymphoma: What you need to know about diagnosis and treatments